Celldex Therapeutics Inc.

A medial security in the Health Care that looks (login to see)

Yahoo! Profile

CLDX

Biological Product (except Diagnostic) Manufacturing
Weighting

Weak Growth

Lead | Lag

Medial

Options

Buying (0.42)

P/E Ratio

12.00

Free Cash Flow

Poor (-35.11)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY